Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

Recruiting

Conditions: Clinical Stage II to III Non-Small Cell Lung Cancer

First Posted Date: 2025-04-02

Last Posted Date: 2025-04-02

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT06907160

Locations: 🇰🇷
Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study

Not yet recruiting

Conditions: Cardiotoxicity
Thoracic Radiotherapy
Wearable Electronic Devices
Thoracic Neoplasms
Atrial Fibrillation

First Posted Date: 2025-03-26

Last Posted Date: 2025-04-18

Lead Sponsor: Yonsei University

Target Recruit Count: 111

Registration Number: NCT06897189

Locations: 🇰🇷
Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea, Republic of

Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study

Phase 4

Recruiting

Conditions: Stroke

Interventions: Drug: Cerebrolyisin
Drug: Placebo

First Posted Date: 2025-03-26

Last Posted Date: 2025-03-26

Lead Sponsor: Yonsei University

Target Recruit Count: 40

Registration Number: NCT06897176

Locations: 🇰🇷
Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Ezetimibe on Gut Microbiota

Phase 4

Recruiting

Conditions: Atherosclerotic Cardiovascular Disease With Dyslipidemia

Interventions: Drug: Atorvastatin 40mg
Drug: Atorvastatin 20mg+Ezetimibe 10mg

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-25

Lead Sponsor: Yonsei University

Target Recruit Count: 110

Registration Number: NCT06784557

Locations: 🇰🇷
Severance hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients

Not Applicable

Recruiting

Conditions: Rhinitis Allergic

First Posted Date: 2025-03-24

Last Posted Date: 2025-03-24

Lead Sponsor: Yonsei University

Target Recruit Count: 44

Registration Number: NCT06890572

Locations: 🇰🇷
Yonsei University, Seoul, Korea, Republic of

Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease

Phase 4

Recruiting

Conditions: Chronic Ulcer of Lower Extremity
Wound
Botulinum Toxins, Type A
Blood Circulation

Interventions: Drug: Botulinum toxin A

First Posted Date: 2025-03-17

Last Posted Date: 2025-03-17

Lead Sponsor: Yonsei University

Target Recruit Count: 15

Registration Number: NCT06878482

Locations: 🇰🇷
Yongin Severance Hospital, Yongin-si, Gyeonggi-do, Korea, Republic of

Pressure Wire Guidance for Infrapopliteal Artery Interventions

Not Applicable

Not yet recruiting

Conditions: Chronic Limb-Threatening Ischemia

First Posted Date: 2025-03-17

Last Posted Date: 2025-03-17

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT06879561

Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring

Phase 3

Not yet recruiting

Conditions: Hypertrophic Cardiomyopathy

First Posted Date: 2025-03-13

Last Posted Date: 2025-03-13

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT06873828

Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation

Not Applicable

Not yet recruiting

Conditions: Atrial Fibrillation on Apixaban Treatment

First Posted Date: 2025-03-11

Last Posted Date: 2025-03-11

Lead Sponsor: Yonsei University

Target Recruit Count: 5200

Registration Number: NCT06869083

Locations: 🇰🇷
Division of Cardiology Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Antithrombotic Strategy for AF Patients With High Risk CAD

Not Applicable

Not yet recruiting

Conditions: Atrial Fibrillation
Coronary Artery Disease

Interventions: Drug: Anticoagulation Monotherapy
Drug: Combination therapy

First Posted Date: 2025-03-10

Last Posted Date: 2025-03-14

Lead Sponsor: Yonsei University

Target Recruit Count: 1400

Registration Number: NCT06866665

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy